COMMUNIQUÉS West-GlobeNewswire

SeaStar Medical to Present Early SAVE Registry Data of QUELIMMUNE in Pediatric Acute Kidney Injury at the 5th International Symposium on Acute Kidney Injury in Children
23/09/2025
DENVER, Sept. 23, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company, announced today that preliminary results from the SAVE Surveillance Registry will be [...]
IO Biotech Announces Late-Breaking Abstract in Advanced Melanoma Selected for Oral Presentation at ESMO Congress 2025
23/09/2025
Oral presentation will highlight the results from the randomized Phase 3 trial (IOB-013/KN-D18) of IO102-IO103 cancer vaccine plus pembrolizumab for first-line (1L) advanced melanoma Poster presentation will share final [...]
Mainz Biomed Announces Commercial Launch of ColoAlert® in Switzerland
23/09/2025
Company Provides Update on eAArly DETECT 2 Study BERKELEY, Calif. and MAINZ, Germany, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic [...]
Solid Biosciences Announces Licensing Agreement with Kinea Bio for the Use of Proprietary Next-Generation Capsid AAV-SLB101
23/09/2025
- Non-exclusive license for Solid’s proprietary, next generation capsid, AAV-SLB101, to accelerate development of Kinea Bio’s gene therapy for dysferlin-related limb-girdle muscular dystrophy - - Solid to receive an [...]
Vanderbilt Report: Coeptis Shows How Biotech Can Fund Itself While Innovating
23/09/2025
COEP Balances Revenue Generation With Breakthrough Cell Therapy Development BRISTOL, Tenn., Sept. 23, 2025 (GLOBE NEWSWIRE) -- VanderbiltReport.com , a financial news and content platform, reports that Coeptis [...]
Texas Prostate and Dallas Medical Center Launch First-of-its-Kind TULSA Program, Expanding Access to Advanced Prostate Treatment
23/09/2025
New program delivers TULSA Procedure’s precision treatment - minimal side effects, no overnight hospital stay – to Medicare patients across Texas TORONTO, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. ( [...]
Hydrafacial Joins Cosmopolitan Readers’ Choice Hall of Fame as Three-Time Winner for Best Pro Facial
23/09/2025
This accolade builds on a year of major awards, reinforcing Hydrafacial’s proven results and trusted position with consumers and providers worldwide LONG BEACH, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) -- The Beauty [...]
Daxor Corporation Unveils Breakthrough Next-Gen BVA Analyzer at HFSA Annual Scientific Meeting
23/09/2025
Additional New Clinical Data To Be Presented Driving a New Standard of Care in Volume Measurement OAK RIDGE, Tenn., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume [...]
Izotropic’s IzoView Breast CT the First in Category to Offer Patent-Pending Personalized Radiation Dose
23/09/2025
- Patent-pending pre-scan technology enables custom radiation dose tailored to patient’s unique breast size and composition - - Feature aligns with personalized medicine trends driving the global breast imaging device [...]
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
23/09/2025
SALT LAKE CITY and BOSTON, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics (Nasdaq: MYGN), a leader in molecular diagnostic testing and precision medicine, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company [...]
InnovAge Appoints Meredith Delk as Executive Vice President and Chief Administrative Officer
23/09/2025
DENVER, Sept. 23, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible [...]
ALPINE WHITE brings Brazil its first peroxide-free dental whitening strips
23/09/2025
Swiss oral-care brand launches a clinically tested at-home whitening range, now available at leading pharmacy chains nationwide RIO DE JANEIRO, Sept. 23, 2025 (GLOBE NEWSWIRE) -- ALPINE WHITE , the Swiss oral-care [...]
Reviva to Participate in the Lytham Partners Fall 2025 Investor Conference
23/09/2025
CUPERTINO, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet [...]
Vanderbilt Report: Full Alliance Group helps Power Hypochlorous Acid’s Breakout from Hospitals to the Global Consumer Market
23/09/2025
BRISTOL, Tenn., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Once relegated to the back rooms of hospitals, hypochlorous acid (HOCl) is rapidly becoming one of the most disruptive platform chemicals of the decade and Full [...]
Amneal Receives U.S. FDA Approval for Bimatoprost Ophthalmic Solution, 0.01%
23/09/2025
Important ophthalmic treatment for patients and expected to be a key growth driver for Amneal’s Affordable Medicines segment BRIDGEWATER, N.J., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” [...]
PROPHASE LABS, INC. ANNOUNCES COMPLETION OF IMPORTANT NEXT STEP FOR CROWN MEDICAL COLLECTIONS $50 MILLION A/R INITIATIVE
23/09/2025
COVID-19 TESTING LABORATORY SUBSIDIARIES FILE FOR BANKRUPCTY PROTECTION UNIONDALE, NY, Sept. 23, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next generation biotech, [...]
High Stakes, High Impact: $20 million from the Weston Family Foundation awarded to cutting-edge health research projects at the forefront of innovation
23/09/2025
McGill University and University of Alberta each awarded $10M to pursue bold research with transformational potential to redefine health outcomes for Canadians TORONTO, Sept. 23, 2025 (GLOBE NEWSWIRE) -- In a move to [...]
Des défis ambitieux, des retombées majeures: La Fondation de la famille Weston attribue 20 millions de dollars pour des projets de recherche de pointe en matière de santé, à l’avant-garde de l’innovation
23/09/2025
L’Université McGill et l’Université de l’Alberta reçoivent chacune 10 millions de dollars pour poursuivre des recherches de pointe susceptibles de transformer la santé des Canadiens. TORONTO, 23 sept. 2025 (GLOBE [...]
Umoja Biopharma Named One of 2025’s Most Promising Biotech Companies by Endpoints News and Fierce Biotech
23/09/2025
SEATTLE, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Umoja Biopharma, the clinical-stage leader of in vivo cell therapies that aim to realize the full reach and promise of CAR T cells, today announced its recognition by both [...]

Pages